✨ Medicines Consent Notices
3698
NEW ZEALAND GAZETTE, No. 126
2 NOVEMBER 2006
Product: Navelbine
Active Ingredient: Vinorelbine tartrate 41.55mg equivalent to vinorelbine 30mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Pierre Fabre Medicament Australia Pty Limited
Manufacturer: R P Scherer & Co. KG., Eberbach/Baden, Germany
Product: Navelbine
Active Ingredient: Vinorelbine tartrate 55.4mg equivalent to vinorelbine 40mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Pierre Fabre Medicament Australia Pty Limited
Manufacturer: R P Scherer & Co. KG., Eberbach/Baden, Germany
Product: Navelbine
Active Ingredient: Vinorelbine tartrate 110.8mg equivalent to vinorelbine 80mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Pierre Fabre Medicament Australia Pty Limited
Manufacturer: R P Scherer & Co. KG., Eberbach/Baden, Germany
Product: Omegaven
Active Ingredients: Egg lecithin 1.2%w/v
Fish oil - highly refined. 10%w/v
Glycerol 2.5%w/v
Dosage Form: Emulsion for infusion
New Zealand Sponsor: Pharmatel Fresenius Kabi NZ Limited
Manufacturers: Fresenius Kabi Austria GmbH, Graz, Austria
Fresenius Kabi Deutschland GmbH, Friedberg, Germany
Product: Ondansetron
Active Ingredient: Ondansetron hydrochloride dihydrate 4.5mg equivalent to Ondansetron 4mg
Dosage Form: Solution for injection
New Zealand Sponsor: Mayne Pharma (NZ) Limited
Manufacturers: Mayne Pharma (Puerto Rico) Inc, Ramey Branch, Aguadilla, Puerto Rico
Mayne Pharma Limited, Mulgrave North, Victoria, Australia
Product: Ondansetron
Active Ingredient: Ondansetron hydrochloride dihydrate 9mg equivalent to Ondansetron 8mg
Dosage Form: Solution for injection
New Zealand Sponsor: Mayne Pharma (NZ) Limited
Manufacturers: Mayne Pharma (Puerto Rico) Inc, Ramey Branch, Aguadilla, Puerto Rico
Mayne Pharma Limited, Mulgrave North, Victoria, Australia
Product: Oxaliplatin Dakota
Active Ingredient: Oxaliplatin 100mg
Dosage Form: Powder for infusion
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Laboratoires Thissen SA, Braine-L’Alleud, Belgium
Product: Oxaliplatin Dakota
Active Ingredient: Oxaliplatin 50mg
Dosage Form: Powder for infusion
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Laboratoires Thissen SA, Braine-L’Alleud, Belgium
Product: Oxaliplatin Winthrop
Active Ingredient: Oxaliplatin 100mg
Dosage Form: Powder for infusion
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Laboratoires Thissen SA, Braine-L’Alleud, Belgium
Product: Oxaliplatin Winthrop
Active Ingredient: Oxaliplatin 50mg
Dosage Form: Powder for infusion
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Laboratoires Thissen SA, Braine-L’Alleud, Belgium
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 126
Gazette.govt.nz —
NZ Gazette 2006, No 126
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social WelfareMedicines, Distribution, Pharmaceuticals, Health